**6. Conclusions**

Vaccines that protect against helminth diseases remain largely elusive in human and veterinary medicine. The successful licensure and deployment of the subunit vaccine Barbervax® provide evidence that the development of next-generation vaccines against parasitic helminths is an attainable goal. Multi-omic approaches allow for the design and evaluation of rationally designed subunit vaccines. The development of successful candidate vaccines has enormous potential to provide protection for the billions of people impacted by helminth diseases.

*Perspective Chapter: Multi-Omic Approaches to Vaccine Development against Helminth Diseases DOI: http://dx.doi.org/10.5772/intechopen.102621*
